You have no items in your shopping cart.
Eriocitrin
SKU: orb1300258
Description
Research Area
Cell Biology, Metabolism Research
Images & Validation
−
Key Properties
−| CAS Number | 13463-28-0 |
|---|---|
| MW | 596.53 |
| Purity | 99.77% |
| Formula | C27H32O15 |
| SMILES | C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3cc(O)c4C(=O)C[C@H](Oc4c3)c3ccc(O)c(O)c3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O |
| Target | Apoptosis,Carbonic Anhydrase |
| Solubility | Pyridine, Methanol, etc.:Soluble;DMSO:91 mg/mL (152.55 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (5.53 mM);Ethanol:Soluble |
Storage & Handling
−| Storage | keep away from direct sunlight,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Carbonic Anhydrase, Carbonic Anhydrase VA isozyme, CarbonicAnhydrase, Apoptosis, inhibit, Inhibitor, Eriodictyol-7-O-Rutinoside, eriodictyol 7-rutinoside, Eriodictyol glycoside, Eriocitrin, Eriodictioside
Similar Products
−Eriocitrin [orb1222739]
>98% (HPLC)
13463-28-0
596.5
C27H32O15
1 g, 500 mg, 200 mg, 50 mg, 100 mg, 5 mg, 10 mg, 25 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Compound Identifiers
PubChem CID
Key Properties
− No computed properties available.
Documents Download
Datasheet
Product Information
Request a Document
Protocol Information
Eriocitrin (orb1300258)
Based on 0 reviews
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review